PTGER4 and cancer: EP4, a Gαs protein coupled receptor expressed mainly on myeloid cells, T lymphocytes, and tumor cells4 has emerged as a major contributor to PGE2-mediated enhancement of tumor survival pathways and also as a suppressor of innate and adaptive anti-tumor immune responses, by triggering cancer-promoting chronic inflammation.5